<DOC>
	<DOCNO>NCT02761395</DOCNO>
	<brief_summary>1 . Evaluate therapeutic effect , health benefit , immunological effect Al-hijamah child beta thalassemia major . 2 . Evaluate extent clinical improvement , reduction serum iron ferritin , antioxidant status , patient .</brief_summary>
	<brief_title>Study The Therapeutic Benefits Al-hijamah Children With Beta Thalassemia Major</brief_title>
	<detailed_description>The present study carry 60 child patient β- thalassemia major attend The Hematology Unit Paediatric Departments Tanta University Hospital . Participants divide 3 group : Group 1 : 20 patient receive Al-hijamah . Group 2 : 20 patient receive Al-hijamah plus iron chelation therapy . Group 3 : 20 patient receive iron chelation therapy Participants undergo : 1 . Laboratory investigation : - CBC ( complete blood count ) peripheral venous blood Al-hijamah daily . - Differences CBC venous blood cup blood ( bloody excretion collect inside suction cup ) . Cupped blood collect heparin coat added suction cup put skin surface . • Serum iron ferritin Al-hijamah . • Serum iron ferritin cup blood v venous blood . • Serum lipid profile glycosylated hemoglobin Al-hijamah . - Total antioxidant capacity serum oxidant e.g . malondialdehyde treatment - Flow cytometric analysis number Natural killer cell , CD4 T helper cell CD4/CD8 cell ( optional ) ( cluster differentiation ) . They report improve markedly Al-hijamah . - Estimating serum LDH , pyruvate ( antioxidant ) lactate ( metabolite pyruvate LDH ) thalassemia patient Al-hijamah 2 . Assessment heart function Echocardiographic study ( 3 month Al-hijamah ) : - line therapy : Technical step Al-hijamah ( Necessary equipment ready patient possible ) : Al-hijamah ( Triple S technique strict sterilization ) : - Strict sterilization select anatomical site . - Suction use sterile plastic disposable suck cup - Skin scarifications ( shartat mihjam ) : induce superficial ( 0.1 mm depth ) , small ( 2 mm length ) , multiple evenly distribute skin incision . - Suction use sterile plastic disposable suck cup - Strict sterilization select anatomical site . Study endpoint : This study terminate safety patient danger due element related new therapeutic agent treatment proven efficacious . 5 . Risks participant reasonable relation anticipate benefit . Many human study prove safety Al-hijamah . 6 . Compensations control transportation work absence patient injury , , description compensation mention . No , compensation . 7 . The proposal include clear statement inform consent obtain participant research .</detailed_description>
	<mesh_term>Thalassemia</mesh_term>
	<mesh_term>beta-Thalassemia</mesh_term>
	<mesh_term>Deferasirox</mesh_term>
	<criteria>Children suffer beta thalassemia major , age range 418 year . Children Congenital heart disease Children Rheumatic heart disease Presence heart failure Children Coronary arterial disease Children Cardiomyopathy Children hypotension Children inflammatory skin diseases e.g . acute burn</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>